National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

HARDBACK
price:$49.95
add to cart

Rights & Permissions

topleft topright

Patient Safety: Achieving a New Standard for Care (2004)
Board on Health Care Services (HCS)
Institute of Medicine (IOM)

Citation Manager

. "6 Adverse Event Analysis." Patient Safety: Achieving a New Standard for Care. Washington, DC: The National Academies Press, 2004.

Please select a format:

BibTeX EndNote RefMan


Page
214
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Patient Safety: Achieving a New Standard for Care

TABLE 6-3 Computerized Physician Order Entry Validation Modules for Medication Prescribing

Validation Module

Generic Data Requirements

Therapeutic duplication

Medications, medication ingredients

Single and cumulative dose limits

Medications, dose levels

Allergies and cross-allergies

Allergies, drug allergies

Contraindicated route of administration

Medications, route of administration

Drug–drug and drug–food interactions

Medications

Contraindication/dose limits based on patient diagnosis

Medications, diagnoses

Contraindication/dose limits based on patient age and weight

Medications, medication dose levels, patient age, weight

Contraindication/dose limits based on laboratory studies

Medications, medication dose levels, laboratory results

Contraindication/dose limits based on radiology studies

Medications, contrast media used in radiology

 

SOURCE: Kilbridge et al., 2001.

tion and the patient’s existing medications. To do this requires data on all the patient’s medications and the ingredients of each.

A list of validation modules that could be incorporated in a computerized physician order entry system is given in Table 6-3, together with the generic data requirements. A full set of validation modules requires a wide range of data elements: medications (including ingredients, dose levels, and administration routes), allergies (including drug allergies), diagnoses, patient age, weight, laboratory results, and contrast media used in radiology.

Implications for Data Standards

The various approaches to adverse event detection discussed above demonstrate that it is not possible to simply identify a small set of clinical data elements specifically for adverse event detection, especially when addressing potential injuries due to errors of omission as well as injuries due to errors of commission. On the contrary, a broad range of data elements encompassing demographic information, signs and symptoms, medications, test results, diagnoses, therapies, and outcomes are required to: (1) detect adverse events through voluntary and mandatory reporting, chart review, and automated surveillance; (2) implement performance measures (e.g., DQIP measures);

Page
214